• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腺嘌呤核苷在大脑功能中的作用:对帕金森病和其他脑部疾病的病理生理影响。

Adenosine role in brain functions: Pathophysiological influence on Parkinson's disease and other brain disorders.

机构信息

Department of Pharmacology, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.

Department of Pharmacology, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.

出版信息

Pharmacol Rep. 2018 Aug;70(4):661-667. doi: 10.1016/j.pharep.2018.02.003. Epub 2018 Feb 3.

DOI:10.1016/j.pharep.2018.02.003
PMID:29909246
Abstract

Although adenosine plays a key role in multiple motor, affective, and cognitive processes, it has received less attention in the neuroscience field compared to other neurotransmitters (e.g., dopamine). In this review, we highlight the role of adenosine in behavior as well as its interaction with other neurotransmitters, such as dopamine. We also discuss brain disorders impacted by alterations to adenosine, and how targeting adenosine can ameliorate Parkinson's disease motor symptoms. We also discuss the role of caffeine (as an adenosine antagonist) on cognition as well as a neuroprotective agent against Parkinson's disease (PD).

摘要

尽管腺苷在多种运动、情感和认知过程中发挥着关键作用,但与其他神经递质(如多巴胺)相比,它在神经科学领域受到的关注较少。在这篇综述中,我们强调了腺苷在行为中的作用及其与其他神经递质(如多巴胺)的相互作用。我们还讨论了受腺苷改变影响的脑部疾病,以及如何通过靶向腺苷来改善帕金森病的运动症状。我们还讨论了咖啡因(作为腺苷拮抗剂)对认知的作用以及其作为帕金森病(PD)神经保护剂的作用。

相似文献

1
Adenosine role in brain functions: Pathophysiological influence on Parkinson's disease and other brain disorders.腺嘌呤核苷在大脑功能中的作用:对帕金森病和其他脑部疾病的病理生理影响。
Pharmacol Rep. 2018 Aug;70(4):661-667. doi: 10.1016/j.pharep.2018.02.003. Epub 2018 Feb 3.
2
Novel neuroprotection by caffeine and adenosine A(2A) receptor antagonists in animal models of Parkinson's disease.咖啡因和腺苷A(2A)受体拮抗剂在帕金森病动物模型中的新型神经保护作用
J Neurol Sci. 2006 Oct 25;248(1-2):9-15. doi: 10.1016/j.jns.2006.05.003. Epub 2006 Jun 27.
3
Pathophysiological roles for purines: adenosine, caffeine and urate.嘌呤的病理生理学作用:腺苷、咖啡因和尿酸。
Prog Brain Res. 2010;183:183-208. doi: 10.1016/S0079-6123(10)83010-9.
4
Effects of caffeine in Parkinson's disease: from neuroprotection to the management of motor and non-motor symptoms.帕金森病中咖啡因的作用:从神经保护到运动和非运动症状的管理。
J Alzheimers Dis. 2010;20 Suppl 1:S205-20. doi: 10.3233/JAD-2010-091459.
5
The adenosine A(2A) receptor as an attractive target for Parkinson's disease treatment.腺苷A(2A)受体作为帕金森病治疗的一个有吸引力的靶点。
Drug News Perspect. 2003 Nov;16(9):597-604. doi: 10.1358/dnp.2003.16.9.829342.
6
Caffeine; the Forgotten Potential for Parkinson's Disease.咖啡因:被遗忘的帕金森病潜在治疗药物。
CNS Neurol Disord Drug Targets. 2017;16(6):652-657. doi: 10.2174/1871527315666161107091149.
7
Caffeine as a lead compound for the design of therapeutic agents for the treatment of Parkinson's disease.咖啡因作为用于设计治疗帕金森病治疗药物的先导化合物。
Curr Med Chem. 2015;22(8):975-88. doi: 10.2174/0929867322666141215160015.
8
A2A adenosine receptor overexpression and functionality, as well as TNF-alpha levels, correlate with motor symptoms in Parkinson's disease.A2A 腺苷受体的过度表达和功能,以及 TNF-α 水平,与帕金森病的运动症状相关。
FASEB J. 2010 Feb;24(2):587-98. doi: 10.1096/fj.09-141044. Epub 2009 Sep 23.
9
Adenosine and dopamine receptor interactions in striatum and caffeine-induced behavioral activation.纹状体中腺苷与多巴胺受体的相互作用及咖啡因诱导的行为激活
Comp Med. 2007 Dec;57(6):538-45.
10
Novel nondopaminergic targets for motor features of Parkinson's disease: review of recent trials.新型非多巴胺能靶点治疗帕金森病运动症状的研究进展:近期临床试验综述。
Mov Disord. 2013 Feb;28(2):131-44. doi: 10.1002/mds.25273. Epub 2012 Dec 5.

引用本文的文献

1
Immune regulatory mechanisms of different exercise methods promoting Parkinson's rehabilitation: A narrative review.不同运动方法促进帕金森病康复的免疫调节机制:一项叙述性综述
Medicine (Baltimore). 2025 Aug 15;104(33):e44035. doi: 10.1097/MD.0000000000044035.
2
Ligand and Residue Free Energy Perturbations Solve the Dual Binding Mode Proposal for an AAR Partial Agonist.配体和残基自由能扰动解决了AAR部分激动剂的双重结合模式问题。
J Phys Chem B. 2025 Jan 23;129(3):886-899. doi: 10.1021/acs.jpcb.4c07391. Epub 2025 Jan 8.
3
Inhibition of ADORA3 promotes microglial phagocytosis and alleviates chronic ischemic white matter injury.
抑制 ADORA3 可促进小胶质细胞吞噬作用,减轻慢性缺血性白质损伤。
CNS Neurosci Ther. 2024 May;30(5):e14742. doi: 10.1111/cns.14742.
4
Metabolic and neurobehavioral disturbances induced by purine recycling deficiency in .嘌呤循环缺陷所致的代谢和神经行为障碍 于……中
Elife. 2024 May 3;12:RP88510. doi: 10.7554/eLife.88510.
5
Mechanisms of motor symptom improvement by long-term Tai Chi training in Parkinson's disease patients.长期太极拳训练改善帕金森病患者运动症状的机制。
Transl Neurodegener. 2022 Feb 7;11(1):6. doi: 10.1186/s40035-022-00280-7.
6
Role of G Protein-Coupled Receptors in Microglial Activation: Implication in Parkinson's Disease.G蛋白偶联受体在小胶质细胞激活中的作用:对帕金森病的影响。
Front Aging Neurosci. 2021 Nov 16;13:768156. doi: 10.3389/fnagi.2021.768156. eCollection 2021.
7
Emerging roles of dysregulated adenosine homeostasis in brain disorders with a specific focus on neurodegenerative diseases.腺苷稳态失调在脑部疾病中的新兴作用,特别关注神经退行性疾病。
J Biomed Sci. 2021 Oct 11;28(1):70. doi: 10.1186/s12929-021-00766-y.
8
Adenosine and Inflammation: Here, There and Everywhere.腺苷与炎症:无处不在。
Int J Mol Sci. 2021 Jul 19;22(14):7685. doi: 10.3390/ijms22147685.
9
Exploration of chalcones and related heterocycle compounds as ligands of adenosine receptors: therapeutics development.探讨查耳酮类和相关杂环化合物作为腺苷受体配体的应用:治疗学开发。
Mol Divers. 2022 Jun;26(3):1779-1821. doi: 10.1007/s11030-021-10257-9. Epub 2021 Jun 27.
10
Decreased Equilibrative Nucleoside Transporter 1 (ENT1) Activity Contributes to the High Extracellular Adenosine Levels in Mesenchymal Glioblastoma Stem-Like Cells.间质型神经胶质瘤干细胞样细胞中低水平的核苷转运蛋白 1(ENT1)活性导致细胞外高浓度腺苷水平。
Cells. 2020 Aug 18;9(8):1914. doi: 10.3390/cells9081914.